Literature DB >> 35242690

Extensive lymphadenopathy leading to cancerous pericardial effusion and tamponade in a T1 pancreatic head adenocarcinoma: a case report.

Mohamed Abdelgawad1, Mahmoud Omar2, Hadeer Eltahan3, Tyler Davis1, Lutfi Barghuthi1, Emad Kandil2, Hisham Ismael1.   

Abstract

In 2019, Pancreatic cancer became the third leading cause of cancer related mortality in the United States of America. Pancreatic cancer is a fatal malignancy that is predominantly seen in men with advanced age with aggressive course. Ninety percent of cases are adenocarcinoma. Pancreatic adenocarcinoma is very difficult to detect as is usually asymptomatic with no early signs. At least 80% of tumors are unresectable by the time of diagnosis. Despite substantial improvement in the survival rates for other major cancer forms, pancreatic cancer survival rates have remained relatively unchanged since 1960s. Multidisciplinary therapy with a combination of chemotherapy, radiation and surgery performed at high volume centers remains the best chance for cure. We report a rare case of a small T1 pancreatic head carcinoma with underlying chronic pancreatitis presenting with cancerous pericardial effusion and tamponade. Despite the small size of the primary tumor, the extensive pattern of lymphatic occlusion can lead to mesenteric and mediastinal lymphatic spread to the pericardium. US guided emergent pericardiocentesis was performed with removal of 750 cc of serosanguinous fluid. Cytopathological examination of the fluid revealed poorly differentiated pancreatic adenocarcinoma. A Port-A-Cath was placed, and he was referred to the oncology department to start chemotherapy. 2022 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Pancreatic adenocarcinoma; cardiac tamponade; case report; lymphadenopathy; pericardial metastasis

Year:  2022        PMID: 35242690      PMCID: PMC8825504          DOI: 10.21037/gs-21-670

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  16 in total

1.  Lymph node size and metastatic infiltration in adenocarcinoma of the pancreatic head.

Authors:  K L Prenzel; A H Hölscher; D Vallböhmer; U Drebber; C A Gutschow; S P Mönig; D L Stippel
Journal:  Eur J Surg Oncol       Date:  2010-07-01       Impact factor: 4.424

2.  Pattern of lymph node metastasis spread in pancreatic cancer.

Authors:  Mitsuro Kanda; Tsutomu Fujii; Shunji Nagai; Yasuhiro Kodera; Akiyuki Kanzaki; Tevfik T Sahin; Masamichi Hayashi; Suguru Yamada; Hiroyuki Sugimoto; Shuji Nomoto; Shin Takeda; Satoshi Morita; Akimasa Nakao
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

Review 3.  Pancreatic cancer.

Authors:  Audrey Vincent; Joseph Herman; Rich Schulick; Ralph H Hruban; Michael Goggins
Journal:  Lancet       Date:  2011-05-26       Impact factor: 79.321

4.  Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours.

Authors:  M J Midwinter; C J Beveridge; J B Wilsdon; M K Bennett; C J Baudouin; R M Charnley
Journal:  Br J Surg       Date:  1999-02       Impact factor: 6.939

5.  Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Margaret A Tempero; Mokenge P Malafa; Mahmoud Al-Hawary; Stephen W Behrman; Al B Benson; Dana B Cardin; E Gabriela Chiorean; Vincent Chung; Brian Czito; Marco Del Chiaro; Mary Dillhoff; Timothy R Donahue; Efrat Dotan; Cristina R Ferrone; Christos Fountzilas; Jeffrey Hardacre; William G Hawkins; Kelsey Klute; Andrew H Ko; John W Kunstman; Noelle LoConte; Andrew M Lowy; Cassadie Moravek; Eric K Nakakura; Amol K Narang; Jorge Obando; Patricio M Polanco; Sushanth Reddy; Marsha Reyngold; Courtney Scaife; Jeanne Shen; Charles Vollmer; Robert A Wolff; Brian M Wolpin; Beth Lynn; Giby V George
Journal:  J Natl Compr Canc Netw       Date:  2021-04-01       Impact factor: 11.908

6.  Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

Authors:  Alok A Khorana; Pamela B Mangu; Jordan Berlin; Anitra Engebretson; Theodore S Hong; Anirban Maitra; Supriya G Mohile; Matthew Mumber; Richard Schulick; Marc Shapiro; Susan Urba; Herbert J Zeh; Matthew H G Katz
Journal:  J Clin Oncol       Date:  2017-04-11       Impact factor: 44.544

Review 7.  Modifiable and non-modifiable risk factors for pancreatic cancer: A review.

Authors:  Shallu Midha; Saurabh Chawla; Pramod Kumar Garg
Journal:  Cancer Lett       Date:  2016-07-25       Impact factor: 8.679

8.  Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.

Authors:  John R Bergquist; Carlos A Puig; Christopher R Shubert; Ryan T Groeschl; Elizabeth B Habermann; Michael L Kendrick; David M Nagorney; Rory L Smoot; Michael B Farnell; Mark J Truty
Journal:  J Am Coll Surg       Date:  2016-02-23       Impact factor: 6.113

9.  Cancerous pericarditis presenting as cardiac tamponade in a 68-year-old man with pancreatic adenocarcinoma: a case report.

Authors:  Sachie Kiryu; Zensho Ito; Masashi Ishikawa; Takafumi Akasu; Yoshihiro Matsumoto; Shinichi Hirooka; Masayuki Saruta; Shigeo Koido
Journal:  J Med Case Rep       Date:  2020-11-07

10.  Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.

Authors:  Ning Pu; Qiangda Chen; Wei Gan; Yuandi Shen; Shanshan Gao; Joseph R Habib; Hanlin Yin; Jicheng Zhang; Benedict Kinny-Köster; Ming Cui; Junhao Li; Yiran Dong; Minako Nagai; Lingxiao Liu; Jun Yu; Wenchuan Wu; Wenhui Lou
Journal:  Adv Ther       Date:  2021-06-26       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.